Inventor · disambiguated record
Qi Pan
Also filed as: PAN QI
7 granted patents·4 pending applications·6 citations·filing 2010–2023
76Inventor score
Top patents by PatentIndex Score
11 records- 0181US10280231B2Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereofBOEHRINGER INGELHEIM INT·Filed 2016·Granted May 7, 2019·3 cites·18 claims
- 0279US11905327B2Single-domain antibodies and variants thereof against TIGITNANJING LEGEND BIOTECH CO LTD·Filed 2018·Granted Feb 20, 2024·1 cites·18 claims
- 0374US10377804B2Anti-BAFF antibodiesBOEHRINGER INGELHEIM INT·Filed 2017·Granted Aug 13, 2019·1 cites·10 claims
- 0474US2024124580A1Single-domain antibodies and variants thereof against tigitNANJING LEGEND BIOTECH CO LTD·Filed 2023·Application pending·0 cites
- 0567US9840543B2Anti-BAFF antibodiesBOEHRINGER INGELHEIM INT·Filed 2015·Granted Dec 12, 2017·1 cites·15 claims
- 0666US11884744B2Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereofBOEHRINGER INGELHEIM INT·Filed 2020·Granted Jan 30, 2024·0 cites·20 claims
- 0765US11370818B2Anti-BAFF antibodiesBOEHRINGER INGELHEIM INT·Filed 2019·Granted Jun 28, 2022·0 cites·8 claims
- 0863US10844138B2Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereofBOEHRINGER INGELHEIM INT·Filed 2019·Granted Nov 24, 2020·0 cites·15 claims
- 0950US2022265709A1Engineered cells and uses thereofNANJING LEGEND BIOTECH CO LTD·Filed 2019·Application pending·0 cites
- 1045US2020369770A1Multispecific antigen binding proteins and methods of use thereofNANJING LEGEND BIOTECH CO LTD·Filed 2019·Application pending·0 cites
- 1135US2012134993A1Compositions and methods for using multispecific-binding proteins comprising an antibody-receptor combinationPAN QI·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Qi Pan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →